Loading...
XETRCOP
Market cap124bUSD
, Last price  
0.00EUR
Name

Conocophillips

Chart & Performance

D1W1MN
XETR:COP chart
P/E
—
P/S
—
EPS
8.47
Div Yield, %
%
Shrs. gr., 5y
0.51%
Rev. gr., 5y
9.70%
Revenues
57.86b
-26.29%
136,916,000,000183,364,000,000167,578,000,000194,495,000,000246,182,000,000152,840,000,000198,655,000,000247,149,000,00057,967,000,00054,413,000,00052,524,000,00029,564,000,00023,693,000,00029,106,000,00036,417,000,00032,567,000,00018,784,000,00045,828,000,00078,494,000,00057,861,000,000
Net income
10.96b
-41.34%
8,129,000,00013,617,000,00015,550,000,00011,891,000,000-16,998,000,0004,858,000,00011,358,000,00012,436,000,0008,428,000,0009,156,000,0006,869,000,000-4,428,000,000-3,615,000,000-855,000,0006,257,000,0007,189,000,000-2,655,000,0008,079,000,00018,680,000,00010,957,000,000
CFO
19.97b
-29.49%
11,959,000,00017,628,000,00021,516,000,00024,550,000,00022,658,000,00012,479,000,00017,045,000,00019,646,000,00013,922,000,00016,087,000,00016,735,000,0007,572,000,0004,403,000,0007,077,000,00012,934,000,00011,104,000,0004,802,000,00016,996,000,00028,314,000,00019,965,000,000
Dividend
May 23, 20241 EUR/sh
Earnings
Feb 06, 2025

Profile

CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment provides practice management software and electronic medical records for registered physicians, medical care centers, and physicians networks, as well as offers supplementary Internet and intranet solutions. The PCS segment provides administrative and billing-related software applications for pharmacies. Its software solution provides information and decision support to manage various aspects of supply chain for medication. The HIS segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute care hospitals, rehabilitation centers, social services, multi-location hospital networks and regional care organizations, and medical laboratories. The CHS segment provides IT security services, data-based product offers, software interface for sharing of information, clinical decision-making support, and medication and treatment databases for healthcare service providers, as well as digital healthcare stock, consumer portals, and mobile apps. This segment also offers security solutions for healthcare providers. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical SE and changed its name to CompuGroup Medical SE & Co. KGaA in June 2020. CompuGroup Medical SE & Co. KGaA was founded in 1987 and is headquartered in Koblenz, Germany.
URL
https://www.conocophillips.com/
IPO date
Mar 17, 1980
Employees
9,700
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
57,861,000
-26.29%
78,494,000
71.28%
45,828,000
143.97%
Cost of revenue
29,749,000
48,552,000
31,122,000
Unusual Expense (Income)
NOPBT
28,112,000
29,942,000
14,706,000
NOPBT Margin
48.59%
38.15%
32.09%
Operating Taxes
5,331,000
9,548,000
4,633,000
Tax Rate
18.96%
31.89%
31.50%
NOPAT
22,781,000
20,394,000
10,073,000
Net income
10,957,000
-41.34%
18,680,000
131.22%
8,079,000
-404.29%
Dividends
(5,583,000)
(5,726,000)
(2,359,000)
Dividend yield
3.99%
3.80%
2.46%
Proceeds from repurchase of equity
(5,452,000)
(8,908,000)
(3,478,000)
BB yield
3.90%
5.91%
3.63%
Debt
Debt current
1,267,000
417,000
1,200,000
Long-term debt
19,709,000
17,652,000
20,194,000
Deferred revenue
6,907,000
Other long-term liabilities
9,460,000
9,027,000
1,414,000
Net debt
5,383,000
601,000
7,690,000
Cash flow
Cash from operating activities
19,965,000
28,314,000
16,996,000
CAPEX
(11,248,000)
(10,159,000)
(5,324,000)
Cash from investing activities
(12,000,000)
(8,741,000)
(8,544,000)
Cash from financing activities
(8,661,000)
(18,053,000)
(6,335,000)
FCF
15,803,000
20,439,000
(14,945,000)
Balance
Cash
6,606,000
9,243,000
6,591,000
Long term investments
8,987,000
8,225,000
7,113,000
Excess cash
12,699,950
13,543,300
11,412,600
Stockholders' equity
53,616,000
47,050,000
35,745,000
Invested Capital
65,985,050
56,936,700
59,386,400
ROIC
37.07%
35.06%
20.50%
ROCE
32.13%
38.29%
19.10%
EV
Common stock shares outstanding
1,205,675
1,278,163
1,328,151
Price
116.07
-1.64%
118.00
63.48%
72.18
80.50%
Market cap
139,942,697
-7.21%
150,823,234
57.33%
95,865,939
122.37%
EV
145,325,697
151,424,234
103,555,939
EBITDA
36,382,000
37,446,000
21,914,000
EV/EBITDA
3.99
4.04
4.73
Interest
1,063,000
1,055,000
1,126,000
Interest/NOPBT
3.78%
3.52%
7.66%